Podhajsky P

Hayreh S S, Podhajsky P, Zimmerman M B

This study found no association between ocular/optic nerve head ischemic disorders and hearing loss; age, not eye disease, was linked to hearing loss, suggesting they are unrelated conditions.

Hayreh S S, Podhajsky P, Zimmerman M B

Beta-blocker eyedrops worsened nocturnal hypotension and heart rate, linking them to visual field progression in normal-tension glaucoma. This suggests they may be a risk factor in susceptible individuals.

Mizener J B, Podhajsky P, Hayreh S S

This study found Ocular Ischemic Syndrome (OIS) often presents with severe vision loss and indicates underlying severe carotid, cerebrovascular, and heart disease, making early ophthalmologic diagnosis critical for systemic health.

Hayreh S S, Zimmerman M B, Podhajsky P, Alward W L

This study found nocturnal hypotension, particularly diastolic, is significantly associated with visual field deterioration in optic nerve disorders like normal-tension glaucoma and AION, suggesting a critical role in their pathogenesis.

Hayreh S S, Klugman M R, Podhajsky P, Servais G E, Perkins E S

Argon laser PRP for ischemic CRVO reduced early iris neovascularization but didn't improve vision or prevent other complications, and worsened peripheral fields, questioning its broad clinical utility.

Hayreh S S, Rojas P, Podhajsky P, Montague P, Woolson R F

This study found severe retinal ischemia in central, hemi, and major branch RVO causes neovascularization, primarily in the anterior segment for CRVO and posterior for hemi/BRVO, emphasizing ischemia's role.